TANIA_2: TANIA, figure 2

In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials

TANIA, figure 2

Description

Kaplan-Meier digitized data from TANIA, figure 2 (PMID 25273342). A reported sample size of 494 for a primary endpoint of PFS in breast cancer.

Usage

TANIA_2

Format

A data frame of 494 observations and 3 variables:

	time	event time (in months)
	event	PFS event indicator (0: no event, 1: event)
	arm	treatment arms (chem_bev, chemo)

Source

von Minckwitz G, Puglisi F, Cortes J, et al. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial. Lancet Oncol 2014; 15: 1269–78.

Examples

summary(TANIA_2)

kmplot(TANIA_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.